安捷凯在线客服
- 客服:
- 电话: 13061953619
- 微信:
ABR-238901 is a novel S100A8/A9 blocker that potently inhibits S100A8/A9 interaction with its receptors RAGE (receptor for advanced glycation endproducts) and TLR4 (toll-like receptor 4).
ABR-238901 is a novel S100A8/A9 blocker that potently inhibits S100A8/A9 interaction with its receptors RAGE (receptor for advanced glycation endproducts) and TLR4 (toll-like receptor 4).
[1] A. Schiopu, et al. European Heart Journal, Volume 38, Issue suppl_1, August 2017, ehx504. [2] De Veirman K, et al.Cancer Immunol Res. 2017 Oct;5(10):839-846
动态评分
0.0